|
ABOUT COMPANY
Atreca, Inc., a biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a variety of solid tumor types. The company is headquartered in South San Francisco, California.
|
EARNINGS
Gross Profit (TTM): 0
Market Capitalization: 112566000
Operating Margin (TTM): 0
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0
Revenue (TTM): 0
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -2.79
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -54735000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|